CATX vs SYF · $280.6M cap vs rev $11.19B
Perspective Therapeutics Inc. (CATX) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
SYF (SYF) common stock.
CATX does not have a complete income-statement cache yet.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
CATX currently screens at market cap $280.6M. SYF currently screens at market cap $0.
Not investment advice. Open the CATX and SYF stock pages for the full models.
Not investment advice.